The hepatic immune niche in liver diseases and transplantation: from homeostasis to therapeutic targeting

Abstract The liver combines continuous exposure to gut-derived antigens and metabolites with immune surveillance and tissue repair. Its immune niche is organized by interactions among sinusoidal endothelial cells, Kupffer cells, recruited leukocytes, and parenchymal and stromal cells. At homeostasis, these interactions support antigen clearance and restrained immune activation. Persistent injury changes antigen presentation, metabolite availability, leukocyte recruitment, and extracellular matrix composition, allowing local immune responses to contribute to continued tissue damage. In chronic viral, steatotic, alcohol-associated, cholestatic, and autoimmune liver diseases, distinct patterns of myeloid activation, lymphocyte dysfunction, cytotoxicity, and fibrogenesis emerge at parenchymal, biliary, and vascular interfaces. Hepatocellular carcinoma (HCC) adds tumor-derived signals that suppress antitumor immunity within a heterogeneous hepatic environment. In liver transplantation, perioperative injury intersects with donor-specific cellular and humoral immunity, with outcomes ranging from controlled donor reactivity to distinct, sometimes overlapping forms of rejection and chronic remodeling. Xenotransplantation further exposes the graft to interspecies antibody, complement, endothelial, and coagulation incompatibilities. In inflammatory liver disease and transplantation, blocking local signals that support pathogenic lymphocyte survival or myeloid activation may reduce continued tissue injury. In HCC, limiting tumor-derived metabolic signals that suppress immune-cell function may instead help restore antitumor responses. Continued recruitment from the circulation may replenish pathogenic populations despite suppression of cells already within the liver, making cellular recruitment an additional potential target. Effective treatment must therefore interrupt the processes sustaining injury while preserving antimicrobial defense, antitumor surveillance, graft regulation, and tissue repair.

Authors

Institutions

Publication Details

Journal
Molecular Biomedicine
Published
2026-11-18
DOI
https://doi.org/10.1186/s43556-026-00657-4
Primary Topic
Liver physiology and pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The hepatic immune niche in liver diseases and transplantation: from homeostasis to therapeutic targeting

Zhipeng Zong, Qiang Xia, Jianjun Zhu, Qianxiao Cheng et al.
Molecular Biomedicine
Liver physiology and pathology
article

The hepatic immune niche in liver diseases and transplantation: from homeostasis to therapeutic targeting

Zhipeng Zong, Qiang Xia, Jianjun Zhu, Qianxiao Cheng, Yongbo Liu, Zhicong Zhao, Aiwei Zhou, Yunmu Gao, Bingran Wang, Hongyuan Liu, Taihua Yang, Jiaqi Song, Yuan Liu, Tao Zhou
article en

Abstract

Abstract The liver combines continuous exposure to gut-derived antigens and metabolites with immune surveillance and tissue repair. Its immune niche is organized by interactions among sinusoidal endothelial cells, Kupffer cells, recruited leukocytes, and parenchymal and stromal cells. At homeostasis, these interactions support antigen clearance and restrained immune activation. Persistent injury changes antigen presentation, metabolite availability, leukocyte recruitment, and extracellular matrix composition, allowing local immune responses to contribute to continued tissue damage. In chronic viral, steatotic, alcohol-associated, cholestatic, and autoimmune liver diseases, distinct patterns of myeloid activation, lymphocyte dysfunction, cytotoxicity, and fibrogenesis emerge at parenchymal, biliary, and vascular interfaces. Hepatocellular carcinoma (HCC) adds tumor-derived signals that suppress antitumor immunity within a heterogeneous hepatic environment. In liver transplantation, perioperative injury intersects with donor-specific cellular and humoral immunity, with outcomes ranging from controlled donor reactivity to distinct, sometimes overlapping forms of rejection and chronic remodeling. Xenotransplantation further exposes the graft to interspecies antibody, complement, endothelial, and coagulation incompatibilities. In inflammatory liver disease and transplantation, blocking local signals that support pathogenic lymphocyte survival or myeloid activation may reduce continued tissue injury. In HCC, limiting tumor-derived metabolic signals that suppress immune-cell function may instead help restore antitumor responses. Continued recruitment from the circulation may replenish pathogenic populations despite suppression of cells already within the liver, making cellular recruitment an additional potential target. Effective treatment must therefore interrupt the processes sustaining injury while preserving antimicrobial defense, antitumor surveillance, graft regulation, and tissue repair.

Molecular BiomedicineVol. 7(1)
Shanghai Jiao Tong University (CN), Renji Hospital (CN)
Liver physiology and pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon